• Corpus ID: 583986

Breast Adenocarcinoma Microenvironment of Patients with Pancreas in Peripheral Blood and Tumor Prevalence of Regulatory T Cells Is Increased

  title={Breast Adenocarcinoma Microenvironment of Patients with Pancreas in Peripheral Blood and Tumor Prevalence of Regulatory T Cells Is Increased},
  author={Peter S. Goedegebuure and Allan Richard Drebin and Steven M. Strasberg and Timothy J. Eberlein and Yoshiyuki Tanaka and Virginia M. Herrmann and Udaya K. Liyanage and Todd T. Moore and Hong-Gu Joo},

Figures and Tables from this paper


Ex Vivo Isolation and Characterization of Cd4+Cd25+ T Cells with Regulatory Properties from Human Blood
It is demonstrated that CD4+CD25+CD45RO+ T cells are present in the blood of adult healthy volunteers, and these cells do not constitute conventional memory cells but rather regulatory cells exhibiting properties identical to their rodent counterparts.
Regulation of the immune response to antigens on the malignant cell surface
The ability of mammalian species to mount immune responses against structures present on the cell surface was discovered by Landsteiner in studies of blood group antigens and led to the study of the immunologic basis of graft rejection phenomena.
Certified Professionals
  • E. Shevach
  • Biology, Medicine
    The Journal of experimental medicine
  • 2001
Although negative selection in the thymus and induction of anergy in the periphery have been widely accepted as mechanisms for controlling autoreactivity, much less attention has been devoted to the
Cutting Edge: Control of CD8+ T Cell Activation by CD4+CD25+ Immunoregulatory Cells
The results broaden the immunoregulatory role played by CD4+CD25+ T cells in the prevention of autoimmune diseases, but also raise the possibility that they may hinder the induction of effector CD8- T cells to tumor or foreign Ags.
Progress in human tumour immunology and immunotherapy
Clinical studies using immunization with peptides derived from cancer antigens have shown that high levels of lymphocytes with anti-tumour activity can be raised in cancer-bearing patients.
Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
T tumor-associated T cells from patients with early and late-stage epithelial tumors contain increased proportions of CD4(+)CD25(+) T cells that secrete the immunosuppressive cytokine transforming growth factor-beta, consistent with the phenotype of regulatory T cells.
Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses
The data demonstrate that the CTL response against melanoma antigens is an important component of the therapeutic antitumor response and that the reactivity of these CTLs can be augmented through interference with immunoregulatory mechanisms.
Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity.
Removal of immunoregulatory CD25+4+ T cells can abrogate immunological unresponsiveness to syngeneic tumors in vivo and in vitro, leading to spontaneous development of tumor-specific effector cells as well as tumor-nonspecific ones.
Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation
One aspect of peripheral self-tolerance is maintained by CD25+ T cells that sustain potentially pathogenic self-reactive T cells in a CD25- dormant state; the thymic production of the former is developmentally programmed to begin on day 3 after birth in mice.